Tuberculosis Resurgent as Trump Funding Cut Disrupts Treatment Globally
The United States was the major funder of tuberculosis programs. Now hundreds of thousands of sick patients can’t find tests or drugs, and risk spreading the disease.
It Is Happening Every Day, Every Where
The United States was the major funder of tuberculosis programs. Now hundreds of thousands of sick patients can’t find tests or drugs, and risk spreading the disease.
Organizations funded by the United States helped keep dangerous pathogens in check around the world. Now many safeguards are gone, and Americans may pay the price.
China could reap the soft-power advantage, but like Western governments, the country is cutting back on aid. Philanthropies say they cannot replace the United States.
Pepfar, which is estimated to have delivered lifesaving treatment as many as 25 million people in 54 countries, faces a funding delay of as long as 180 days.